Lv1
40 积分 2026-03-19 加入
Diagnostic and prognostic performance of the SAFE score in non‐alcoholic fatty liver disease
27天前
已完结
Prognostic performance of the two-step clinical care pathway in metabolic dysfunction-associated steatotic liver disease
27天前
已完结
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
27天前
已完结
Non-alcoholic fatty liver disease
27天前
已完结
Screening for Metabolic Dysfunction–Associated Steatotic Liver Disease–Related Advanced Fibrosis in Diabetology: A Prospective Multicenter Study
1个月前
已完结
Degree of Discordance Between FIB-4 and Transient Elastography: An Application of Current Guidelines on General Population Cohort
1个月前
已完结
FIB-4 Score in Young Healthy Adults and Its Association With End Stage Liver Disease: A Nationwide Retrospective Study
1个月前
已关闭
Effectiveness of Six International Guidelines Using Fibrosis-4 and FibroScan for Risk Stratification of Metabolic Dysfunction-associated Steatotic Liver Disease in Type 2 Diabetes
1个月前
已完结
Real-world Comparison of Steatosis-Associated Fibrosis Estimator and Fibrosis-4 Scores for Assessing Metabolic Dysfunction-associated Steatotic Liver Disease-related Fibrosis in a Highly Diverse Urban Metabolic Dysfunction-associated Steatotic Liver Disease Population
1个月前
已完结
皖公网安备34019202002308
